Endotronix
endotronix.com
Actively hiring
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$258M
6 rounds on record
Latest round
$69.3M
Venture round · Sep 2018 · 8 yr ago
Team
146
US Form 5500 (plan participants) · Dec 2024
Backers
1
Lumira Ventures
The money's age
Long since its last round
96 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 14, 2018
Raised a round Series D $45M
Jul 5, 2016
Raised a round Venture round $37.1M · SEC Form D
Jul 5, 2016
Raised a round Venture round $37.1M · SEC Form D
Oct 12, 2010
Raised a round Venture round $250k · MedCity News
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Sep 2018 | $69.3M | — | SEC Form D |
| Venture round | Sep 2018 | $69.3M | — | SEC Form D |
| Series D | Sep 2018 | $45M | — | mobihealthnews.com |
| Venture round | Jul 2016 | $37.1M | — | SEC Form D |
| Venture round | Jul 2016 | $37.1M | — | SEC Form D |
| Venture round | Oct 2010 | $250k | — | MedCity News |
Registers and programsofficial lists and records that name the company
| Legal entity | ENDOTRONIX INC | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Harry RowlandExecutive Officer, DirectorSEC Form D
Anthony NunezExecutive OfficerSEC Form D
Kent ElmerExecutive OfficerSEC Form D
John FlavinExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Lumira Ventures Similar startupsby what they do, their industry and backers
The Corvia® Atrial Shunt is designed to reduce symptoms associated with heart failure (HF), reduce HF hospitalizations, and improve quality…
Alleviant Medical's interatrial shunt therapy without an implant is currently being evaluated in heart failure patients. FDA approved…
Gene therapy for advanced coronary artery disease. XyloCor Therapeutics is focused on improving the lives of patients through our…
Replacing Hearts. Restoring Lives. HEART FAILURE Heart failure is a global epidemic affecting at least 26 million people worldwide, 6.2…
Redefining heart failure by enabling early & safe treatment - Puzzle Medical Devices® Inc. is a Canadian company specializing in the…
Home Approach Product About News Contact News We're on a mission to improve patient outcomes. Our values guide us on our mission to…
News
Edwards Lifesciences to Acquire Endotronix
Irvine-based Edwards Lifesciences Corp. agreed to acquire Endotronix Inc. on July 24.
Read more
Report
Endotronix Receives FDA Premarket Approval of the Cordella PA Sensor System for the Treatment of Heart Failure
/PRNewswire/ -- Endotronix, Inc., a privately held company dedicated to advancing the treatment of heart failure (HF) at the intersection of digital health and...
Read more
Report
Endotronix Submits PMA Application for its Cordella Pulmonary Artery Sensor System
/PRNewswire/ -- Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), today announced...
Read more
Report
Endotronix reports promising study results for sensor used to manage heart failure
The startup's Cordella Pulmonary Artery Pressure Sensor System, which was implanted in 70 heart failure patients in Europe, led to low hospitalization rates and high patient compliance with daily measurements needed to monitor them remotely.
Read more
Report
Pro access
Upgrade to see all 12 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
People
Harry Rowland
Executive Officer, Director
Anthony Nunez
Executive Officer
Kent Elmer
Executive Officer
John Flavin
Executive Officer
Robert Zieserl
Director
James Hummer
Director
Marc Goldberg
Director
Paul LaViolette
Director
Gerry Brunk
Director
Jennifer McMahon
Director
Fouad Azzam
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Woodridge
United States
HQ
Financials
Total raised
$258M
Latest round
Venture - Series Unknown
Funding rounds
6